Target intelligence / Profile preview

SMT3 suppressor of mif two 3 homolog 2, pseudogene

Molecular classification
Other
01

Overview

ENSG00000267800 corresponds to a **pseudogene** of the SMT3 suppressor of mif two 3 homolog 2 (SUMO2) gene rather than to a functional protein-coding gene or direct therapeutic target[4]. Pseudogenes are non-functional genomic DNA sequences similar to known genes but typically do not produce active proteins. The true gene, SUMO2 (small ubiquitin-like modifier 2), is a member of the SUMO protein family involved in post-translational modification of other proteins and diverse cellular processes such as nuclear transport and regulation of transcription[1][3][6]. However, as a pseudogene, ENSG00000267800 does not encode a functional protein and has no established therapeutic, biological, or disease role. **Clarification:** There is a functional gene, **SUMO2** (small ubiquitin-like modifier 2), which is often studied for its cellular and disease relevance, but ENSG00000267800 specifically refers to a **pseudogene** version, which is not an active drug target[4]. If you seek information on the active SUMO2 protein, use the entry ENSG00000188612 instead[3]. **Summary of issues:** - ENSG00000267800 is a pseudogene and not a functional molecule of therapeutic interest[4]. - It is not considered a valid drug target, nor does it have known protein, disease, or drug associations. - Any search for functional data should use the canonical SUMO2 gene rather than its pseudogene counterpart.

Other names
SMT3 suppressor of mif two 3 homolog 2, pseudogeneSUMO2 pseudogeneSMT3H2 pseudogenesmall ubiquitin-like modifier 2 pseudogeneENSG00000267800

Beyond the preview

Go deeper on SMT3 suppressor of mif two 3 homolog 2, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMT3 suppressor of mif two 3 homolog 2, pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call